Paravalvular leak (PVL) is very common after TAVI and has been reported to have a
negative impact on both short-and long-term survival. The current study identified incidence …

Aortic stenosis is the most common valvular disease requiring valve replacement. Valve
replacement therapies have undergone progressive evolution since the 1960s. Over the last …

Background Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) and redo
surgical aortic valve replacement (SAVR) represent the 2 treatments for aortic bioprosthesis …

OBJECTIVES The aim of this study was to compare biological versus mechanical aortic
valve replacement. METHODS We searched MEDLINE, Scopus and Cochrane Library …

Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is
an appealing alternative to redo surgical AVR. We utilized data from the US National …

Prothesis-patient mismatch (PPM) occurs when there is a mismatch between the effective
orifice area (EOA) of the prosthetic valve and the required cardiac output to meet the need of …

Abstract Background/Aim With the growing contemporary use of bioprosthetic valves, whose
limited long‐term durability has been well‐documented, an increase in the need for …

Transcatheter aortic valve replacement (TAVR) has emerged as a ground‐breaking,
minimally invasive alternative to traditional open‐heart surgery, primarily designed for …

Background Clinical outcomes of redo surgical aortic valve replacement (redo-SAVR)
compared with valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) are poorly …

Background The use of bioprostheses for surgical aortic valve replacement increased
substantially within the last years. In case of prosthesis failure, re-SAVR is standard of care …